MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ganderton C et al. | Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial. | 2016 | BMC Womens Health | pmid:27312538 |
Brynhildsen J | [Not Available]. | 2016 | Lakartidningen | pmid:27299335 |
Liu X et al. | Probing Steroidal Substrate Specificity of Cytochrome P450 BM3 Variants. | 2016 | Molecules | pmid:27294908 |
Soliman AM et al. | Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy. | 2016 | J Manag Care Spec Pharm | pmid:27123918 |
Hofmeyr GJ et al. | Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. | 2016 | Reprod Health | pmid:27091008 |
Maybin JA and Critchley HO | Medical management of heavy menstrual bleeding. | 2016 | Womens Health (Lond) | pmid:26695687 |
Román M et al. | Postmenopausal hormone therapy and the risk of breast cancer in Norway. | 2016 | Int. J. Cancer | pmid:26289549 |
Cano-Nicolau J et al. | Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish. | 2016 | Toxicol. Appl. Pharmacol. | pmid:27245768 |
Hasegawa S et al. | Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. | 2017 | PLoS ONE | pmid:28732067 |